Orthopedic device manufacturer Implanet reported more than $3.3 million in revenue during the third quarter of 2025, according to an Oct. 7 news release from the company.
Here are five financial notes to know:
- The company’s 2025 third quarter revenue represents a 26% increase from the third quarter in 2024.
- Implanet has a nine-month 2025 revenue of more than $10 million, an increase of 36% compared to the same period last year.
- U.S. activity grew 22% in the third quarter of 2025 compared to 2024.
- Implanet’s U.S. revenue surpassed $1 million in the third quarter of 2025, driven by the initial roll out of the company’s Jazz Spinal System.
- Revenue from spine implants increased 33% in 2025’s third quarter compared to 2024, and medical equipment revenue climbed 13% over the same period.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
